Loading clinical trials...
Loading clinical trials...
This is a single-center prospective cohort study to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry.
The primary objective of this study is to determine whether a two-week course of daily ACV supplementation significantly changes an individual's urine chemistry. The investigators will study this in healthy individuals and individuals with kidney stones.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
The University of Chicago
Chicago, Illinois, United States
Start Date
March 1, 2026
Primary Completion Date
January 1, 2028
Completion Date
February 1, 2028
Last Updated
February 5, 2026
30
ESTIMATED participants
Apple Cider Vinegar
DIETARY_SUPPLEMENT
Lead Sponsor
University of Chicago
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions